SCHEMBL5374302

SCHEMBL5374302

Cc1cc(Cc2ccc(Br)c(Oc3cccc(C#N)c3)c2F)n[nH]c1=O

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
EPAS1 Q99814 4/20 0.35
PIK3R1 P27986 3/20 0.33
PIK3CA P42336 3/20 0.33
VEGFA P15692 1/20 0.32
SLC5A2 P31639 1/20 0.32
MAP4K4 O95819 1/20 0.31
GSK3A P49840 1/20 0.31
DRD1 P21728 1/20 0.31
MAPK14 Q16539 1/20 0.31
TDP2 O95551 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5370521 0.92 CYP3A4 (0.67) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL5370387 0.90 CYP3A4 (0.65) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL5368624 0.89 CYP3A4 (0.80) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL5368936 0.88 CYP3A4 (0.72) CYP3A4CYP2C9CYP2C19SLC5A2KCNH2
SCHEMBL5372639 0.86 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL5376896 0.84 CYP3A4 (0.65) CYP3A4CYP2C9CYP2C19PIK3R1PIK3CA
SCHEMBL5668069 0.83 CYP3A4 (0.76) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL5374191 0.82 CYP3A4 (0.75) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL4279184 0.81 CYP3A4 (0.74) CYP3A4CYP2C9CYP2C19PRMT5WDR77
SCHEMBL4274657 0.80 CYP3A4 (0.91) CYP3A4CYP2C9CYP2C19EPAS1PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed